Prostate cancer is one of the most common types of cancer in men and typically occurs at older ages. This cancer develops in the prostate gland and, while it is often slow-growing, it may show more aggressive characteristics in some patients. Therefore, early diagnosis and accurate treatment planning are of great importance.
In the early stages, prostate cancer may not cause noticeable symptoms. In more advanced stages, symptoms such as difficulty urinating, frequent urination, weak urine flow, or blood in the urine may occur. Regular check-ups enable prostate cancer to be detected at an early stage.
Diagnosis and Evaluation Process
The diagnosis of prostate cancer is primarily based on the PSA (Prostate-Specific Antigen) test, clinical examination, and prostate biopsy. When necessary, magnetic resonance imaging and other advanced diagnostic tests are used to evaluate the extent of tumor involvement within the prostate and its relationship with surrounding tissues.
Based on the findings, the stage and risk group of the disease are determined, and an individualized treatment plan is developed for the patient.
Treatment Approach
Treatment of prostate cancers is planned according to the stage of the disease, its biological characteristics, and the patient’s age and overall health status. In early-stage disease, active surveillance may be considered, while surgical or other treatment approaches may be recommended in appropriate cases.
The primary goals of treatment are to control the cancer, prevent disease progression, and preserve the patient’s quality of life. Treatment decisions are made based on individual evaluation and scientific evidence.
Post-Treatment Follow-up
After treatment, patients are enrolled in a regular follow-up program. The course of the disease is monitored through PSA testing, clinical evaluations, and imaging studies when necessary.
This follow-up process is crucial for early detection of recurrence and for achieving long-term healthy outcomes.
